{"entity":{"type":"insider","cik":"0001856094","url":"/insider/0001856094","json_url":"/insider/0001856094.json","name":"Borgeson Blake","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":71,"n_filings":65,"first":"2021-11-22","last":"2026-08-06","span_basis":"filed_date"},"name_variants":[{"name":"Borgeson Blake","source":"filing","n_filings":65,"first_seen":"2021-11-22","last_seen":"2026-08-06"}],"transactions":[{"id":5806485,"accession":"0001856094-26-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856094-26-000014","line_url":"/filing/0001856094-26-000014#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":97500.0,"total_display":"97,500.00","total_whole":"97,500","shares_owned_after":6188287.0,"shares_owned_after_display":"6,188,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-04","filed_date":"2026-08-06","scope":"insider"},{"id":5950760,"accession":"0001856094-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856094-26-000011","line_url":"/filing/0001856094-26-000011#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":3.9625,"price_display":"3.96","price_state":"stated","total_value":158500.0,"total_display":"158,500.00","total_whole":"158,500","shares_owned_after":6218287.0,"shares_owned_after_display":"6,218,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-09","scope":"insider"},{"id":6230727,"accession":"0001856094-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856094-26-000008","line_url":"/filing/0001856094-26-000008#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":110400.0,"total_display":"110,400.00","total_whole":"110,400","shares_owned_after":6169863.0,"shares_owned_after_display":"6,169,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-04","scope":"insider"},{"id":6120522,"accession":"0001856094-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856094-26-000005","line_url":"/filing/0001856094-26-000005#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":105600.0,"total_display":"105,600.00","total_whole":"105,600","shares_owned_after":6199863.0,"shares_owned_after_display":"6,199,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-07","scope":"insider"},{"id":5841256,"accession":"0001856094-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856094-26-000003","line_url":"/filing/0001856094-26-000003#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":93000.0,"total_display":"93,000.00","total_whole":"93,000","shares_owned_after":6229863.0,"shares_owned_after_display":"6,229,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-08","scope":"insider"},{"id":5933186,"accession":"0001601830-26-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-26-000045","line_url":"/filing/0001601830-26-000045#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":170000.0,"shares_display":"170,000","price_per_share":3.46,"price_display":"3.46","price_state":"stated","total_value":588200.0,"total_display":"588,200.00","total_whole":"588,200","shares_owned_after":6259863.0,"shares_owned_after_display":"6,259,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":5906953,"accession":"0001601830-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-26-000007","line_url":"/filing/0001601830-26-000007#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220000.0,"shares_display":"220,000","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":924000.0,"total_display":"924,000.00","total_whole":"924,000","shares_owned_after":6429863.0,"shares_owned_after_display":"6,429,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-06","scope":"insider"},{"id":5779585,"accession":"0001856094-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856094-26-000002","line_url":"/filing/0001856094-26-000002#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220000.0,"shares_display":"220,000","price_per_share":4.36,"price_display":"4.36","price_state":"stated","total_value":959200.0,"total_display":"959,200.00","total_whole":"959,200","shares_owned_after":6649863.0,"shares_owned_after_display":"6,649,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":5061765,"accession":"0001856094-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856094-25-000006","line_url":"/filing/0001856094-25-000006#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220000.0,"shares_display":"220,000","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":961400.0,"total_display":"961,400.00","total_whole":"961,400","shares_owned_after":6869863.0,"shares_owned_after_display":"6,869,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":3095202,"accession":"0001601830-24-000205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000205","line_url":"/filing/0001601830-24-000205#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":7.6402,"price_display":"7.64","price_state":"stated","total_value":87457.3694,"total_display":"87,457.37","total_whole":"87,457","shares_owned_after":7066113.0,"shares_owned_after_display":"7,066,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-14","scope":"insider"},{"id":2259005,"accession":"0001601830-24-000186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000186","line_url":"/filing/0001601830-24-000186#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":6.7202,"price_display":"6.72","price_state":"stated","total_value":76926.1294,"total_display":"76,926.13","total_whole":"76,926","shares_owned_after":7077560.0,"shares_owned_after_display":"7,077,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-10-31","scope":"insider"},{"id":2193049,"accession":"0001601830-24-000179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000179","line_url":"/filing/0001601830-24-000179#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":6.6678,"price_display":"6.67","price_state":"stated","total_value":76326.3066,"total_display":"76,326.31","total_whole":"76,326","shares_owned_after":7089007.0,"shares_owned_after_display":"7,089,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider"},{"id":3260814,"accession":"0001601830-24-000166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000166","line_url":"/filing/0001601830-24-000166#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":6.2156,"price_display":"6.22","price_state":"stated","total_value":71149.9732,"total_display":"71,149.97","total_whole":"71,150","shares_owned_after":7098428.0,"shares_owned_after_display":"7,098,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider"},{"id":3211702,"accession":"0001601830-24-000160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000160","line_url":"/filing/0001601830-24-000160#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":6.8431,"price_display":"6.84","price_state":"stated","total_value":78332.9657,"total_display":"78,332.97","total_whole":"78,333","shares_owned_after":7109875.0,"shares_owned_after_display":"7,109,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-19","scope":"insider"},{"id":2224696,"accession":"0001601830-24-000154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000154","line_url":"/filing/0001601830-24-000154#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":6.2652,"price_display":"6.27","price_state":"stated","total_value":71717.7444,"total_display":"71,717.74","total_whole":"71,718","shares_owned_after":7121322.0,"shares_owned_after_display":"7,121,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"},{"id":2429195,"accession":"0001601830-24-000129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000129","line_url":"/filing/0001601830-24-000129#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":7.1226,"price_display":"7.12","price_state":"stated","total_value":81532.4022,"total_display":"81,532.40","total_whole":"81,532","shares_owned_after":7132769.0,"shares_owned_after_display":"7,132,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":2092602,"accession":"0001601830-24-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000119","line_url":"/filing/0001601830-24-000119#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":6.8213,"price_display":"6.82","price_state":"stated","total_value":78083.4211,"total_display":"78,083.42","total_whole":"78,083","shares_owned_after":7144216.0,"shares_owned_after_display":"7,144,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-06","filed_date":"2024-08-08","scope":"insider"},{"id":2511427,"accession":"0001601830-24-000104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000104","line_url":"/filing/0001601830-24-000104#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":8.4774,"price_display":"8.48","price_state":"stated","total_value":97040.7978,"total_display":"97,040.80","total_whole":"97,041","shares_owned_after":7155663.0,"shares_owned_after_display":"7,155,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-23","filed_date":"2024-07-25","scope":"insider"},{"id":2611163,"accession":"0001601830-24-000100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000100","line_url":"/filing/0001601830-24-000100#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":7.315,"price_display":"7.32","price_state":"stated","total_value":83734.805,"total_display":"83,734.80","total_whole":"83,735","shares_owned_after":7167110.0,"shares_owned_after_display":"7,167,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-11","scope":"insider"},{"id":2092600,"accession":"0001601830-24-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000094","line_url":"/filing/0001601830-24-000094#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":9.5052,"price_display":"9.51","price_state":"stated","total_value":108806.0244,"total_display":"108,806.02","total_whole":"108,806","shares_owned_after":7177116.0,"shares_owned_after_display":"7,177,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-27","scope":"insider"},{"id":2114882,"accession":"0001601830-24-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000082","line_url":"/filing/0001601830-24-000082#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":8.4531,"price_display":"8.45","price_state":"stated","total_value":96762.6357,"total_display":"96,762.64","total_whole":"96,763","shares_owned_after":7188563.0,"shares_owned_after_display":"7,188,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-13","scope":"insider"},{"id":2320153,"accession":"0001601830-24-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000067","line_url":"/filing/0001601830-24-000067#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":9.1677,"price_display":"9.17","price_state":"stated","total_value":104942.6619,"total_display":"104,942.66","total_whole":"104,943","shares_owned_after":7186913.0,"shares_owned_after_display":"7,186,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":2731765,"accession":"0001601830-24-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000055","line_url":"/filing/0001601830-24-000055#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20054.0,"shares_display":"20,054","price_per_share":10.1194,"price_display":"10.12","price_state":"stated","total_value":202934.4476,"total_display":"202,934.45","total_whole":"202,934","shares_owned_after":7198360.0,"shares_owned_after_display":"7,198,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":2290574,"accession":"0001601830-24-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000046","line_url":"/filing/0001601830-24-000046#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":7.9465,"price_display":"7.95","price_state":"stated","total_value":90963.5855,"total_display":"90,963.59","total_whole":"90,964","shares_owned_after":7218414.0,"shares_owned_after_display":"7,218,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-30","filed_date":"2024-05-02","scope":"insider"},{"id":2567527,"accession":"0001601830-24-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000037","line_url":"/filing/0001601830-24-000037#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":7.6636,"price_display":"7.66","price_state":"stated","total_value":87725.2292,"total_display":"87,725.23","total_whole":"87,725","shares_owned_after":7229861.0,"shares_owned_after_display":"7,229,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-16","filed_date":"2024-04-18","scope":"insider"},{"id":2488547,"accession":"0001601830-24-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000027","line_url":"/filing/0001601830-24-000027#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":8.8182,"price_display":"8.82","price_state":"stated","total_value":100941.9354,"total_display":"100,941.94","total_whole":"100,942","shares_owned_after":7241308.0,"shares_owned_after_display":"7,241,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":2511420,"accession":"0001601830-24-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000024","line_url":"/filing/0001601830-24-000024#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20054.0,"shares_display":"20,054","price_per_share":10.792,"price_display":"10.79","price_state":"stated","total_value":216422.768,"total_display":"216,422.77","total_whole":"216,423","shares_owned_after":7252755.0,"shares_owned_after_display":"7,252,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-21","scope":"insider"},{"id":2258967,"accession":"0001601830-24-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601830-24-000021","line_url":"/filing/0001601830-24-000021#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20054.0,"shares_display":"20,054","price_per_share":12.0577,"price_display":"12.06","price_state":"stated","total_value":241805.1158,"total_display":"241,805.12","total_whole":"241,805","shares_owned_after":7272809.0,"shares_owned_after_display":"7,272,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":3042220,"accession":"0001209191-24-003708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-003708","line_url":"/filing/0001209191-24-003708","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20054.0,"shares_display":"20,054","price_per_share":12.32297124264486,"price_display":"12.32","price_state":"stated","total_value":247124.8653,"total_display":"247,124.87","total_whole":"247,125","shares_owned_after":7293172.0,"shares_owned_after_display":"7,293,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider","n_lines":2},{"id":2793623,"accession":"0001209191-24-003000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-003000","line_url":"/filing/0001209191-24-003000#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":9.3028,"price_display":"9.30","price_state":"stated","total_value":106489.1516,"total_display":"106,489.15","total_whole":"106,489","shares_owned_after":7312917.0,"shares_owned_after_display":"7,312,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":3132089,"accession":"0001209191-24-002250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002250","line_url":"/filing/0001209191-24-002250#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20054.0,"shares_display":"20,054","price_per_share":10.5756,"price_display":"10.58","price_state":"stated","total_value":212083.0824,"total_display":"212,083.08","total_whole":"212,083","shares_owned_after":7324364.0,"shares_owned_after_display":"7,324,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider"},{"id":2842755,"accession":"0001209191-24-001484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001484","line_url":"/filing/0001209191-24-001484","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20054.0,"shares_display":"20,054","price_per_share":13.623339179216117,"price_display":"13.62","price_state":"stated","total_value":273202.4439,"total_display":"273,202.44","total_whole":"273,202","shares_owned_after":7344418.0,"shares_owned_after_display":"7,344,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-11","scope":"insider","n_lines":2},{"id":8548510,"accession":"0001209191-23-059947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059947","line_url":"/filing/0001209191-23-059947#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20054.0,"shares_display":"20,054","price_per_share":10.6285,"price_display":"10.63","price_state":"stated","total_value":213143.939,"total_display":"213,143.94","total_whole":"213,144","shares_owned_after":7364472.0,"shares_owned_after_display":"7,364,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":8023957,"accession":"0001209191-23-058701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058701","line_url":"/filing/0001209191-23-058701#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":7.3987,"price_display":"7.40","price_state":"stated","total_value":84692.9189,"total_display":"84,692.92","total_whole":"84,693","shares_owned_after":7384526.0,"shares_owned_after_display":"7,384,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-14","scope":"insider"},{"id":8753991,"accession":"0001209191-23-056998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056998","line_url":"/filing/0001209191-23-056998#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":6.7195,"price_display":"6.72","price_state":"stated","total_value":76918.1165,"total_display":"76,918.12","total_whole":"76,918","shares_owned_after":7395973.0,"shares_owned_after_display":"7,395,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2023-11-30","scope":"insider"},{"id":8190361,"accession":"0001209191-23-055613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055613","line_url":"/filing/0001209191-23-055613#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":6.3197,"price_display":"6.32","price_state":"stated","total_value":56150.5345,"total_display":"56,150.53","total_whole":"56,151","shares_owned_after":7407420.0,"shares_owned_after_display":"7,407,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":7923721,"accession":"0001209191-23-054225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054225","line_url":"/filing/0001209191-23-054225#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":5.2745,"price_display":"5.27","price_state":"stated","total_value":46863.9325,"total_display":"46,863.93","total_whole":"46,864","shares_owned_after":7416305.0,"shares_owned_after_display":"7,416,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-31","filed_date":"2023-11-02","scope":"insider"},{"id":7999716,"accession":"0001209191-23-053196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053196","line_url":"/filing/0001209191-23-053196#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":6.5822,"price_display":"6.58","price_state":"stated","total_value":58482.847,"total_display":"58,482.85","total_whole":"58,483","shares_owned_after":7425190.0,"shares_owned_after_display":"7,425,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-10-19","scope":"insider"},{"id":8501967,"accession":"0001209191-23-052258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052258","line_url":"/filing/0001209191-23-052258#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":7.2907,"price_display":"7.29","price_state":"stated","total_value":64777.8695,"total_display":"64,777.87","total_whole":"64,778","shares_owned_after":7434075.0,"shares_owned_after_display":"7,434,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":8255077,"accession":"0001209191-23-050318","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050318","line_url":"/filing/0001209191-23-050318#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":8.3599,"price_display":"8.36","price_state":"stated","total_value":74277.7115,"total_display":"74,277.71","total_whole":"74,278","shares_owned_after":7442960.0,"shares_owned_after_display":"7,442,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":8405061,"accession":"0001209191-23-048695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048695","line_url":"/filing/0001209191-23-048695#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":8.7942,"price_display":"8.79","price_state":"stated","total_value":78136.467,"total_display":"78,136.47","total_whole":"78,136","shares_owned_after":7451845.0,"shares_owned_after_display":"7,451,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"},{"id":8753159,"accession":"0001209191-23-047239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047239","line_url":"/filing/0001209191-23-047239#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":8.9118,"price_display":"8.91","price_state":"stated","total_value":79181.343,"total_display":"79,181.34","total_whole":"79,181","shares_owned_after":7460730.0,"shares_owned_after_display":"7,460,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-24","scope":"insider"},{"id":8470172,"accession":"0001209191-23-045330","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-045330","line_url":"/filing/0001209191-23-045330","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17770.0,"shares_display":"17,770","price_per_share":11.158313370849747,"price_display":"11.16","price_state":"stated","total_value":198283.2286,"total_display":"198,283.23","total_whole":"198,283","shares_owned_after":7472887.0,"shares_owned_after_display":"7,472,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-10","scope":"insider","n_lines":2},{"id":8752793,"accession":"0001209191-23-043579","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043579","line_url":"/filing/0001209191-23-043579#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18719.0,"shares_display":"18,719","price_per_share":14.6089,"price_display":"14.61","price_state":"stated","total_value":273463.9991,"total_display":"273,464.00","total_whole":"273,464","shares_owned_after":7487385.0,"shares_owned_after_display":"7,487,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-27","scope":"insider"},{"id":8439801,"accession":"0001209191-23-042225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042225","line_url":"/filing/0001209191-23-042225#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":6.8873,"price_display":"6.89","price_state":"stated","total_value":61193.6605,"total_display":"61,193.66","total_whole":"61,194","shares_owned_after":7520104.0,"shares_owned_after_display":"7,520,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":7898494,"accession":"0001209191-23-040206","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040206","line_url":"/filing/0001209191-23-040206#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8885.0,"shares_display":"8,885","price_per_share":7.3876,"price_display":"7.39","price_state":"stated","total_value":65638.826,"total_display":"65,638.83","total_whole":"65,639","shares_owned_after":7528989.0,"shares_owned_after_display":"7,528,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider"},{"id":8680003,"accession":"0001209191-23-037584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037584","line_url":"/filing/0001209191-23-037584#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856094","owner_name":"Borgeson Blake","owner_display_name":"Borgeson Blake","owner_url":"/insider/0001856094","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15485.0,"shares_display":"15,485","price_per_share":9.9778,"price_display":"9.98","price_state":"stated","total_value":154506.233,"total_display":"154,506.23","total_whole":"154,506","shares_owned_after":7525262.0,"shares_owned_after_display":"7,525,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"}],"collapsed":true,"next_cursor":"2023-06-13|8680003","ledger_fault":false,"count":{"value":71,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":71,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":71},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Director","n_filings":65,"first_seen":"2021-11-22","last_seen":"2026-08-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001856094","retrieved_at":"2026-08-23T13:28:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}